WS #16342
Amid the broad market selloff, defensive sectors are showing relative strength. Roche reported a revenue beat in its Q3 results, providing a positive outlier in the healthcare space. Additionally, data from Kering and market commentary indicated that the high-end skincare and beauty segments are significantly more resilient than luxury fashion, with China leading the recovery. This divergence suggests investors are rotating into essential consumer goods and healthcare stocks that offer pricing power and stability in an inflationary environment.
Pharma and Defensive Rotation
Amid the broad market selloff, defensive sectors are showing relative strength. Roche reported a revenue beat in its Q3 results, providing a positive outlier in the healthcare space. Additionally, data from Kering and market commentary indicated that the high-end skincare and beauty segments are significantly more resilient than luxury fashion, with China leading the recovery. This divergence suggests investors are rotating into essential consumer goods and healthcare stocks that offer pricing power and stability in an inflationary environment.